Disorders of Blood and Reticuloendothelial System
Introduction
Blood performs several essential functions in the human body. It transports oxygen and nutrients, protects the body against infections, helps prevent blood loss and maintains the internal environment.
These functions depend on healthy red blood cells (RBCs), white blood cells (WBCs), platelets and plasma. Disorders of blood develop when one or more of these components are abnormal.
The reticuloendothelial system (RES), also called the mononuclear phagocyte system, consists mainly of specialised cells called monocytes and macrophages. These cells remove old or damaged blood cells, foreign particles and microorganisms.
Understanding blood and RES disorders helps explain how changes in blood-cell production, function or removal can affect normal body activities.
[IMG 1 — Horizontal medical infographic showing red blood cells, white blood cells, platelets and plasma, alongside the bone marrow, spleen and liver. Label their basic roles: oxygen transport, immune defence, clotting and removal of aged blood cells.]
1. Classification of Blood Disorders
Blood disorders can be classified according to the blood component or process affected.
A. Red Blood Cell Disorders
These disorders affect the number, structure or function of RBCs.
Examples include:
Anemia: Reduced haemoglobin concentration, which may decrease the oxygen-carrying capacity of blood.
Polycythemia: An abnormally increased concentration of red blood cells.
Hemolytic disorders: Conditions in which RBCs are destroyed earlier than normal.
Sickle cell disease: An inherited disorder in which abnormal haemoglobin can cause RBCs to become sickle-shaped.
B. White Blood Cell Disorders
These disorders affect the number or function of WBCs.
Examples include:
Leukopenia: A reduced number of circulating WBCs.
Leukocytosis: An increased number of circulating WBCs.
Leukemia: A group of cancers involving abnormal growth of blood-forming cells, commonly affecting WBC-producing tissues.
C. Platelet and Coagulation Disorders
These disorders affect platelet function or the blood-clotting process.
Examples include:
Thrombocytopenia: Reduced platelet count.
Hemophilia: An inherited deficiency of specific clotting factors.
Thrombosis: Formation of a blood clot inside a blood vessel.
Disseminated intravascular coagulation (DIC): Widespread activation of clotting that may lead to both clot formation and bleeding.
2. Disorders of Red Blood Cells
A. Anemia
Anemia is a condition in which the haemoglobin concentration of blood is below the expected range for a person's age, sex and physiological condition.
Haemoglobin carries oxygen from the lungs to body tissues. When haemoglobin decreases, the oxygen-carrying capacity of blood may also decrease.
Common symptoms include:
Fatigue and weakness
Shortness of breath, especially during activity
Dizziness or light-headedness
Pale skin or mucous membranes
Palpitations
Anemia may develop due to three main mechanisms:
Reduced RBC production: The bone marrow does not produce enough RBCs.
Increased RBC destruction: RBCs are destroyed faster than they can be replaced.
Blood loss: RBCs are lost through bleeding.
Anemia is not a single disease. Its treatment depends on the underlying cause.
Important: Iron supplements are useful when iron deficiency is present, but they are not appropriate for every type of anemia.
B. Polycythemia
Polycythemia refers to an abnormally increased concentration of RBCs in the blood. This may occur because the body produces too many RBCs or because plasma volume decreases.
When RBC concentration becomes significantly elevated, blood may become more viscous, making it harder to flow through blood vessels.
Possible symptoms include:
Headache
Dizziness
Redness of the skin
Visual disturbances
Itching in some cases
Polycythemia is broadly classified into two types:
Primary polycythemia: RBC production increases due to a problem within the bone marrow. Polycythemia vera is an example.
Secondary polycythemia: RBC production increases in response to elevated erythropoietin (EPO), often because of reduced oxygen availability.
For example, people living at high altitudes may produce more RBCs as an adaptation to lower oxygen levels.
Clinical importance: Excessive RBC concentration can increase blood viscosity and may raise the risk of blood clots.
C. Bone Marrow Hyperplasia and Hypoplasia
The bone marrow is the main site of blood-cell production. Its activity changes according to the body's requirements.
Bone marrow hyperplasia means increased blood-forming activity. It may occur when the body needs to replace blood cells more rapidly, such as during increased RBC destruction.
In some severe inherited anemias, prolonged overactivity of the bone marrow may cause expansion of marrow spaces and changes in bone structure.
Bone marrow hypoplasia means reduced blood-forming activity. When the bone marrow produces too few blood cells, the number of RBCs, WBCs or platelets may decrease.
A severe form of bone marrow failure is called aplastic anemia. It may cause a reduction in all three major blood-cell types, known as pancytopenia.
[IMG 2 — Horizontal comparison diagram showing normal bone marrow, hyperactive bone marrow with increased blood-cell production, and hypoplastic marrow with reduced blood-cell production. Use simple labels and avoid advanced cellular details.]
3. Disorders of White Blood Cells
A. Leukopenia
Leukopenia is a reduction in the number of circulating white blood cells.
WBCs help protect the body against infections. Therefore, significant leukopenia may increase susceptibility to infection.
Possible causes include:
Certain viral infections
Bone marrow suppression
Some medicines
Autoimmune conditions
Nutritional deficiencies
Neutropenia is a specific type of leukopenia in which the number of neutrophils is reduced. Severe neutropenia can increase the risk of serious infections.
B. Leukocytosis
Leukocytosis is an increase in the number of circulating white blood cells.
It may occur as a response to:
Infection
Inflammation
Physical stress
Certain medicines
The type of WBC that increases may provide clues about the underlying cause.
For example, neutrophils often increase during many bacterial infections. However, leukocytosis is a laboratory finding rather than a diagnosis by itself.
C. Leukemia
Leukemia is a group of cancers involving abnormal proliferation of blood-forming cells, commonly in the bone marrow.
Abnormal cells may accumulate in the bone marrow and interfere with the production of normal RBCs, WBCs and platelets.
As a result, a person may develop:
Fatigue and weakness due to anemia
Frequent or persistent infections
Easy bruising or bleeding
Fever
Bone pain
Enlarged lymph nodes in some cases
Diagnosis requires appropriate blood tests and may include examination of the bone marrow.
4. Disorders of Platelets and Blood Coagulation
A. Thrombocytopenia
Thrombocytopenia is a condition in which the platelet count is lower than the normal range.
Platelets help form the initial plug at an injured blood vessel. A reduced platelet count may therefore increase the tendency to bleed.
Possible manifestations include:
Easy bruising
Small red or purple spots on the skin called petechiae
Nosebleeds
Bleeding from the gums
Prolonged bleeding from minor injuries
Thrombocytopenia may occur due to reduced platelet production, increased platelet destruction or increased platelet consumption.
B. Hemophilia
Hemophilia is an inherited bleeding disorder caused by deficiency or dysfunction of specific clotting factors.
The two major forms are:
Hemophilia A: Deficiency of clotting factor VIII.
Hemophilia B: Deficiency of clotting factor IX.
Clotting factors help form a stable blood clot. When their activity is reduced, bleeding may continue for longer than usual.
Bleeding may occur in joints, muscles or other tissues.
Remember: Hemophilia affects clotting factors, whereas thrombocytopenia involves a reduced platelet count.
C. Thrombosis
Thrombosis is the formation of a blood clot, called a thrombus, within a blood vessel.
A thrombus may partially or completely obstruct blood flow. The effect depends on its location and size.
Examples include:
Deep vein thrombosis (DVT): A clot in a deep vein, commonly in the leg.
Pulmonary embolism: A clot that travels to and blocks a blood vessel in the lungs.
Arterial thrombosis: A clot in an artery that may interfere with blood supply to organs.
Thrombosis is important because it can reduce blood flow and damage tissues.
D. Disseminated Intravascular Coagulation (DIC)
DIC is a serious condition in which clotting is activated throughout the circulation.
Small clots may form in blood vessels and consume platelets and clotting factors. As these components are used up, the patient may also develop severe bleeding.
DIC may occur as a complication of serious conditions such as severe infection, major trauma or certain obstetric complications.
It requires urgent medical assessment and treatment of the underlying cause.
5. The Reticuloendothelial System
The reticuloendothelial system (RES), more accurately called the mononuclear phagocyte system, consists mainly of monocytes and macrophages.
These cells engulf and remove microorganisms, foreign particles, cellular debris and aged or damaged blood cells.
Major Components of the RES
Bone marrow: Produces blood cells and contains macrophages involved in blood-cell development and removal.
Spleen: Filters blood and removes aged or damaged RBCs.
Liver: Contains specialised macrophages called Kupffer cells, which remove particles and cellular material from blood.
Lymph nodes: Contain macrophages and other immune cells that help filter lymph and support immune responses.
[IMG 3 — Horizontal labelled anatomical infographic showing the bone marrow, spleen, liver with Kupffer cells and lymph nodes. Use arrows to show how macrophages remove aged RBCs, cellular debris and microorganisms.]
6. Functions of the Reticuloendothelial System
A. Removal of Aged and Damaged RBCs
RBCs normally circulate for approximately 120 days. As they age or become damaged, macrophages—especially in the spleen and liver—remove them from circulation.
The components of haemoglobin are then processed and recycled.
B. Phagocytosis
Macrophages engulf and digest microorganisms, foreign particles and cellular debris.
This process, called phagocytosis, helps protect the body against infection and removes unwanted material.
C. Immune Defence
Macrophages help detect harmful substances and support immune responses. They also interact with other immune cells to coordinate the body's defence against infections.
D. Recycling of Iron
When aged RBCs are broken down, iron from haemoglobin can be recovered and reused for the production of new RBCs in the bone marrow.
This recycling helps conserve iron and supports normal RBC production.
7. Splenomegaly and Hypersplenism
A. Splenomegaly
Splenomegaly means enlargement of the spleen.
The spleen filters blood and removes aged or damaged RBCs. It may enlarge when its workload increases or when certain diseases affect it.
Possible causes include:
Increased removal of abnormal blood cells
Certain infections
Liver diseases that cause increased pressure in the portal circulation
Some blood disorders
An enlarged spleen may sometimes cause discomfort or a feeling of fullness in the upper left part of the abdomen.
B. Hypersplenism
Hypersplenism is a condition in which an enlarged or overactive spleen removes or stores excessive numbers of circulating blood cells.
This may lead to reduced numbers of RBCs, WBCs or platelets in the blood, even when the bone marrow is still producing cells.
Easy distinction:
Splenomegaly: The spleen is enlarged.
Hypersplenism: The spleen is overactive and removes or stores too many blood cells.
8. Clinical and Pharmacological Importance
Understanding blood disorders is important in pharmacy because medicines, nutritional deficiencies and underlying diseases can affect blood-cell production, survival and function.
Some important treatment principles include:
Iron-deficiency anemia: Iron replacement may be used when iron deficiency is confirmed.
Vitamin B12 deficiency: Vitamin B12 replacement may be required.
Folate deficiency: Folic acid may be used when folate deficiency is identified.
Anemia due to chronic kidney disease: Erythropoiesis-stimulating medicines may be prescribed in selected cases.
Immune-related blood disorders: Treatment may involve medicines that reduce abnormal immune activity.
Important safety note: Vitamin B12 deficiency should not be treated with folic acid alone without appropriate assessment. Folic acid may improve the anemia while neurological damage due to B12 deficiency continues.
Treatment must be based on the underlying cause and appropriate medical assessment. Not every blood disorder requires the same medicine.
Key Takeaways
Blood disorders may affect RBCs, WBCs, platelets or clotting factors.
Anemia reduces haemoglobin concentration and may decrease oxygen delivery to tissues.
Polycythemia involves an increased RBC concentration and may increase blood viscosity.
Bone marrow hyperplasia means increased blood-forming activity, while hypoplasia means reduced activity.
Leukopenia and leukocytosis describe reduced and increased WBC counts, respectively.
Thrombocytopenia affects platelet number, while hemophilia affects clotting-factor function.
Thrombosis involves clot formation inside a blood vessel; DIC involves widespread clotting activation with possible bleeding.
The RES removes aged blood cells, supports immune defence and helps recycle iron.
Splenomegaly means an enlarged spleen, while hypersplenism means excessive storage or removal of blood cells by the spleen.